Beilstein Journal of Organic Chemistry 2009, 5, No. 26.
ppm]; IR (ATR): ν = 1717, 1649, 1583, 1545, 1451, 1250, evaporated to yield an orange solid. The crude product was
1193, 1096, 1053, 970, 756 cm−1.
purified by flash column chromatography (CHCl3:MeOH –
50:1). Yield: 186 mg, 280 μmol, 58%, orange solid; Rf = 0.15
(CHCl3:MeOH – 50:1); mp 255–259 °C (decomp.); 1H NMR
(CDCl3) δ = 0.91–1.05 (m, 12 H, 3 × CH3 + 3 × Hax), 1.48 (s, 9
H, Boc-CH3), 2.39 (s, 3 H, Ar-CH3), 2.48 (s, 3 H, Ar-CH3),
2.64–2.69 (m, 3 H, Heq), 3.48 (s, 3 H, N-CH3), 3.98 (tr, J = 4.53
Hz, 2 H, CH2), 4.84 (br s, 2 H, CH2), 7.30 (s, 1 H, Ar-H) 7.99
(s, 1 H, Ar-H), 8.33 (br s, 1 H, N-H), 8.85 (br s, 1 H, N-H); 13C
3-{2-[10-(2-Methoxyethyl)-7,8-dimethyl-2,4-
dioxobenzo[g]pteridin-3(2H,4H,10H)-yl]ethyl}-
1,5,7-trimethyl-2,4-dioxo-3-
azabicyclo[3.3.1]nonane-7-carboxylic acid;
Flavin–Kemp’s acid 9
DMAP (460 mg, 2.8 mmol) and Kemp’s anhydride (5) (370 NMR (CDCl3) δ = 19.5 (Ar-CH3) 21.9 (Ar-CH3), 25.5 (2 ×
mg, 1.54 mmol) were added successively to a solution of flavin CH3), 28.1 (Boc-CH3), 28.8 (N-CH3), 31.3 (CH3), 37.2
salt 8 (570 mg, 1.50 mmol) in water (50 mL) and the solution (N-CH2), 40.1 (2 × Cqu), 42.3 (CH2), 43.3 (CH2), 44.1
was refluxed for 20 h. After cooling, the mixture was brought to (N-CH2), 44.5 (Cqu), 83.8 (Boc-Cqu), 115.1 (C9), 131.9 (C9a),
pH 1 with hydrochloric acid (5 M), and the precipitating dark 132.8 (C6), 134.7 (C5a), 135.8 (C4a), 136.3 (C7), 146.8 (C8),
orange product was collected by filtration. As thin layer chro- 149.3 (C10a), 153.0 (NHCO), 156.0 (C2), 158.7 (Boc-CO),
matography showed considerable amounts of the product in the 160.2 (C4), 177.5 (NHCO); ES-MS m/z (%): 681.4 [M+NH4]+,
filtrate, it was concentrated and purified by flash column chro- 663.4 (100) [M+H]+, 563.3 [M+H-Boc]+; HRMS–EI m/z: calcd
matography (CHCl3:MeOH – 15:1), to yield another portion of for C33H43N8O7 [M+H]+: 663.3255; found: 663.3242 [Δ 1.92
orange solid. Yield: 597 mg, 1.06 mmol, 71%, orange solid; Rf ppm] IR (ATR): ν = 1716, 1668, 1634, 1584, 1543, 1455, 1367,
= 0.2 (CHCl3:MeOH – 10:1); mp 305 °C (decomp.); 1H NMR 1327, 1236, 1144, 968, 756 cm−1.
(DMSO-d6) δ = 0.97 (s, 6 H, 2 × Kemps-CH3), 1.04 (s, 3 H,
Kemps-CH3), 1.15 (d, J = 13.72 Hz, 2 H, Hax), 1.32 (d, J =
N-(Boc-Carbamimidoyl)-3-{2-[10-(2-meth-
12.62 Hz, 1 H, Hax), 1.82 (d, J = 12.62 Hz, 1 H, Heq), 2.25 (d, J
oxyethyl)-7,8-dimethyl-2,4-dioxobenzo[g]pter-
= 13.17 Hz, 2 H, Heq), 2.41 (s, 3 H, Ar-CH3), 2.50 (s, 3 H,
idin-3(2H,4H,10H)-yl]ethyl}-1,5,7-trimethyl-
Ar-CH3, hidden by DMSO), 3.22 (s, 3 H, O-CH3), 3.74–3.77
2,4-dioxo-3-azabicyclo[3.3.1]nonane-7-
(m, 4 H, 2 × CH2), 4.06–4.07 (m, 2 H, N-CH2), 4.83 (tr, J =
5.35 Hz, 2 H, O-CH2), 7.91 (s, 1 H, Ar-H), 7.98 (s, 1 H, Ar-H), carboxamide; Flavin-Boc-guanidin 10
12.25 (br s, 1 H, COOH); 13C NMR (DMSO-d6) δ = 18.8 (Ar- To a solution of HOBt·H2O (226 mg, 1.67 mmol), EDC (226
CH3), 20.8 (Ar-CH3), 25.0 (CH3), 29.9 (CH3), 37.4, 41.0, 41.6 mg, 1.45 mmol) and DIPEA (498 μL, 970 μmol) in CHCl3 (10
and 43.1 (Cqu and CH2), 44.0 (10-N-CH2), 58.5 (O-CH3), 68.3 mL) was added compound 9 (548 mg, 969 μmol) and mono
(O-CH2), 116.9 (C9), 130.9 (C6), 131.5 (C9a), 134.0 (C5a), Boc-protected guanidine (231 mg, 1.45 mmol) at 0 °C. The
135.6 (C4a), 136.3 (C7), 147.0 (C8), 148.6 (C10a), 155.0 (C2), mixture was stirred at room temperature for 20 h, diluted with
159.7 (C4), 176.1 und 176.6 (COOH und CONH); ES-MS m/z CHCl3 (250 mL) and washed with water and brine. The organic
(%): 566.3 (100) [M+H]+; HRMS–EI m/z: calcd for phase was separated, dried over magnesium sulfate and the
C29H36N5O7 [M+H]+: 566.2615; found: 566.2623 [Δ −1.46 solvents were evaporated. The crude brown product was puri-
ppm]; IR (ATR): ν = 1719, 1673, 1621, 1581, 1548, 1234, fied by flash column chromatography (CHCl3:MeOH:N(Et)3 –
1119, 953, 886, 806, 758 cm−1.
70:1:1). Yield: 564 mg, 798 μmol, 82%, yellow solid; Rf = 0.1
(CHCl3:MeOH:TEA – 50:1:1); mp 229–231 °C (decomp.); 1H
NMR (CDCl3) δ = 0.93–1.21 (m, 12 H, 3 × CH3 + 3 × Hax),
1.46 (s, 9 H, Boc-CH3), 2.15 (d, J = 12.90 Hz, 1 H, Heq), 2.38
(s, 3 H, Ar-CH3), 2.48 (s, 3 H, Ar-CH3), 2.68 (d, J = 13.44 Hz,
2 H, Heq), 3.22 (s, 3 H, O-CH3), 3.80–3.84 (m, 4 H, 2 × CH2),
4.20–4.22 (m, 2 H, CH2), 4.79 (tr, J = 5.08 Hz, 2 H, CH2), 7.58
(s, 1 H, Ar-H) 7.94 (s, 1 H, Ar-H), 8.27 (br s, 1 H, N-H), 8.75
N-(Boc-Carbamimidoyl)-1,5,7-trimethyl-2,4-
dioxo-3-{2-[3,7,8-trimethyl-2,4-dioxo-3,4-
dihydrobenzo[g]pteridin-10(2H)-yl]ethyl}-3-
azabicyclo[3.3.1]nonane-7-carboxamide;
Flavin-Boc-guanidin 7
To a solution of HOBt·H2O (89 mg, 580 μmol), EDC (90 mg, (br s, 1 H, N-H); 13C NMR (CDCl3) δ = 19.5 (Ar-CH3) 21.5
580 μmol) and DIPEA (171 μL, 970 μmol) in CH2Cl2 (6.5 mL) (Ar-CH3), 25.5 (2 × CH3), 28.1 (Boc-CH3), 31.3 (CH3), 38.4
were added compound 6 (252 mg, 480 μmol) and mono Boc- (N-CH2), 40.2 (2 × Cqu), 40.8 (N-CH2), 43.2 (N-CH2), 44.2 (2
protected guanidine (86 mg, 530 μmol) at 0 °C. The mixture × CH2), 44.6 (Cqu), 45.2 (CH2), 59.2 (O-CH3), 69.6 (O-CH2),
was stirred at room temperature for 20 h, diluted with CHCl3 83.4 (Boc-Cqu), 116.6 (C9), 132.2 (C9a), 132.2 (C6), 134.9
(150 mL) and washed with brine twice. The organic phase was (C5a), 135.6 (C4a), 136.4 (C7), 147.2 (C8), 148.7 (C10a),
separated, dried over magnesium sulfate and the solvents were 153.4 (NHCO), 156.1 (C2), 158.5 (Boc-CO), 160.4 (C4), 177.5
Page 6 of 9
(page number not for citation purposes)